Rodent strain differences in the NPFF1 and NPFF2 receptor distribution and density in the central nervous system

Brain Research

Volumn 1014, Issue 1-2, 2004, Pages 61-70

  Gouarderes C ^a   Faura, C C ^b   Zajac, J M ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b INSTITUTO DE NEUROCIENCIAS   (Spain)

Author keywords

7; Aa; Acb; accumbens nucleus; AD; AH; amygdaloid area; anterodorsal thalamic nucleus; Autoradiography; Central nervous system; facial nucleus; Neuropeptide FF receptors; Neurotransmitters, modulators and receptors; NPFF receptor; Rodent; Strain difference

Indexed keywords

GLUTAMYLTYROSYLTRYPTOPHYLSERYLLEUCYLALANYLALANYLPROLYLGLUTAMINYLARGINYLPHEN YLALANINAMIDE; IODINE 125; NEUROPEPTIDE FF 1 RECEPTOR; NEUROPEPTIDE FF 2 RECEPTOR; NEUROPEPTIDE RECEPTOR; TYROSYLVALYLPROLYLASPARAGINYLLEUCYLPROLYLGLUTAMINYLARGINYLPHENYLALANINAMIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING SITE; BRAIN; BRAIN CORTEX; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CERVICAL SPINAL CORD; CONTROLLED STUDY; EVALUATION; FOREBRAIN; IN VITRO STUDY; INFERIOR COLLICULUS; ISOTOPE LABELING; MESENCEPHALON; MOUSE; MOUSE STRAIN; NEUROANATOMY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RAT STRAIN; RECEPTOR BINDING; RECEPTOR DENSITY; RHOMBENCEPHALON; RODENT; SOLITARY TRACT NUCLEUS; SPECIES COMPARISON; SPINAL CORD; STRAIN DIFFERENCE; STRUCTURE ANALYSIS; TELENCEPHALON; THALAMUS NUCLEUS;

ANIMALS; AUTORADIOGRAPHY; BINDING SITES; BRAIN; MICE; MICE, INBRED C57BL; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE; SPECIES SPECIFICITY; TISSUE DISTRIBUTION;

EID: 2942744342     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.04.005     Document Type: Article

References (47)

1. Allard M., Zajac J.-M., Simonnet G. Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine-modulating peptide, in rat central nervous system. Neuroscience. 49:1992;101-116
2. Ballet S., Mauborgne A., Gouarderes C., Bourgoin A.S., Zajac J.M., Hamon M., Cesselin F. The neuropeptide FF analogue, 1DME, enhances in vivo met-enkephalin release from the rat spinal cord. Neuropharmacology. 38:1999;1317-1324
3. Bonini J.A., Jones K.A., Adham N., Forray C., Artymyshyn R., Durkin M.M., Smith K.E., Tamm J.A., Boteju L.W., Lakhlani P.P., Raddatz R., Yao W.J., Ogozalek K.L., Boyle N., Kouranova E.V., Quan Y., Vaysse P.J., Wetzel J.M., Branchek T.A., Gerald C., Borowsky B. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J. Biol. Chem. 275:2000;39324-39331
4. Bonnard E., Burlet-Schiltz O., Frances B., Mazarguil H., Monsarrat B., Zajac J.M., Roussin A. Identification of neuropeptide FF-related peptides in rodent spinal cord. Peptides. 22:2001;1085-1092
5. Bonnard E., Burlet-Schiltz O., Monsarrat B., Girard J.-P., Zajac J.-M. Identification of proNeuropeptide FFA peptides processed in neuronal and non-neuronal cells and in nervous tissue. Eur. J. Biochem. 270:2003;4187-4199
6. Clark F.M., Proudfit H.K. Anatomical evidence for genetic differences in the innervation of the rat spinal cord by noradrenergic locus coeruleus neurons. Brain Res. 591:1992;44-53
7. Dupouy V., Zajac J.M. Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis. Regul. Pept. 59:1995;349-356
8. Dupouy V., Zajac J.M. Neuropeptide FF receptors in rat brain: a quantitative light-microscopic autoradiographic study using [125I][D. Tyr1, (NMe)Phe3]NPFF. Synapse. 24:1996;282-296
9. Elshourbagy N.A., Ames R.S., Fitzgerald L.R., Foley J.J., Chambers J.K., Szekeres P.G., Evans N.A., Schmidt D.B., Buckley P.T., Dytko G.M., Murdock P.R., Milligan G., Groarke D.A., Tan K.B., Shabon U., Nuthulaganti P., Wang D.Y., Wilson S., Bergsma D.J., Sarau H.M. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J. Biol. Chem. 275:2000;25965-25971
10. Franklin K., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1997;Academic Press, San Diego, CA, USA
11. Gelot A., Francés B., Roussin A., Latapie J.-P., Zajac J.-M. Anti-opioid efficacy of Neuropeptide FF in morphine-tolerant mice. Brain Res. 808:1998;166-173
12. Gherardi N., Zajac J.M. Neuropeptide FF receptors of mouse olfactory bulb: binding properties and stimulation of adenylate cyclase activity. Peptides. 18:1997;577-583
13. Gouarderes C., Jhamandas K., Sutak M., Zajac J.M. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues. Br. J. Pharmacol. 117:1996;493-501
14. Gouarderes C., kar S., Zajac J.M. Presence of neuropeptide FF receptors on primary afferent fibres of the rat spinal cord. Neuroscience. 74:1996;21-27
15. Gouarderes C., Tafani J.A., Mazarguil H., Zajac J.M. Autoradiographic characterization of rat spinal neuropeptide FF receptors by using [125I][D. Tyr1, (NMe)Phe3]NPFF. Brain Res. Bull. 42:1997;231-238
16. Gouarderes C., Tafani J.A., Zajac J.M. Affinity of neuropeptide FF analogs to opioid receptors in the rat spinal cord. Peptides. 19:1998;727-730
17. Gouarderes C., Roumy M., Advokat C., Jhamandas K., Zajac J.M. Dual localization of neuropeptide FF receptors in the rat dorsal horn. Synapse. 35:2000;45-52
18. Gouarderes C., Quelven I., Mollereau C., Mazarguil H., Rice S.Q., Zajac J.M. Quantitative autoradiographic distribution of NPFF1 neuropeptide FF receptor in the rat brain and comparison with NPFF2 receptor by using [125I]YVP and [125I]EYF as selective radioligands. Neuroscience. 115:2002;349-361
19. Gouarderes C., Puget A., Zajac J.-M. Detailed distribution of neuropeptide FF receptors (NPFF1 and NPFF2) in the rat, mouse, octodon, rabbit, guinea pig, and marmoset monkey brains: a comparative autoradiographic study. Synapse. 51:2004;249-269
20. Hinuma S., Shintani Y., Fukusumi S., Iijima N., Matsumoto Y., Hosoya M., Fujii R., Watanabe T., Kikuchi K., Terao Y., Yano T., Yamamoto T., Kawamata Y., Habata Y., Asada M., Kitada C., Kurokawa T., Onda H., Nishimura O., Tanaka M., Ibata Y., Fujino M. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat. Cell Biol. 2:2000;703-708
21. Kest B., Jenab S., Brodsky M., Sadowski B., Belknap J.K., Mogil J.S., Inturrisi C.E. Mu and delta opioid receptor analgesia, binding density, and mRNA levels in mice selectively bred for high and low analgesia. Brain Res. 816:1999;381-389
22. Kest B., Wilson S.G., Mogil J.S. Sex differences in supraspinal morphine analgesia are dependent on genotype. J. Pharmacol. Exp. Ther. 289:1999;1370-1375
23. 2- adrenergic and μ-opioid spinal antinociception by neuropeptide FF. Peptides. 16:1995;973-977
24. Kotani M., Mollereau C., Detheux M., Le Poul E., Brezillon S., Vakili J., Mazarguil H., Vassart G., Zajac J.M., Parmentier M. Functional characterization of a human receptor for neuropeptide FF and related peptides. Br. J. Pharmacol. 133:2001;138-144
25. Liu Q., Guan X.M., Martin W.J., McDonald T.P., Clements M.K., Jiang Q., Zeng Z., Jacobson M., Williams D.L. Jr., Yu H., Bomford D., Figueroa D., Mallee J., Wang R., Evans J., Gould R., Austin C.P. Identification and characterization of novel mammalian neuropeptide ff-like peptides that attenuate morphine-induced antinociception. J. Biol. Chem. 276:2001;36961-36969
26. Mas M., Sabater E., Olaso M.J., Horga J.F., Faura C.C. Genetic variability in morphine sensitivity and tolerance between different strains of rats. Brain Res. 866:2000;109-115
27. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le M.M., Dolle P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature. 383:1996;819-823
28. Mauborgne A., Bourgoin S., Polienor H., Roumy M., Simonnet G., Zajac J.M., Cesselin F. The neuropeptide FF analogue, 1DMe, acts as a functional opioid autoreceptor antagonist in the rat spinal cord. Eur. J. Pharmacol. 430:2001;273-276
29. Mazarguil H., Gouarderes C., Tafani J.M., Marcus D., Kotani M., Mollereau C., Roumy M., Zajac J.-M. Structure-activity relationships of neuropeptide FF: role of C-terminal regions. Peptides. 22:2001;1471-1478
30. Mogil J.S. The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc. Natl. Acad. Sci. U. S. A. 96:1999;7744-7751
31. Mogil J.S., Chesler E.J., Wilson S.G., Juraska J.M., Sternberg W.F. Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype. Neurosci. Biobehav. Rev. 24:2000;375-389
32. Mollereau C., Mazarguil H., Marcus D., Quelven I., Kotani M., Lannoy V., Dumont Y., Quirion R., Detheux M., Parmentier M., Zajac J.M. Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists. Eur. J. Pharmacol. 451:2002;245-256
33. Oguzhanoglu A., Kurt T. Findings of somatosensory evoked potential to stimulation of the sciatic nerve in two different rat strains. Exp. Anim. 50:2001;361-364
34. Panula P., Aarnisalo A.A., Wasowicz K. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog. Neurobiol. 48:1996;461-487
35. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1998;535 Academic Press, Sydney, Australia
36. Perry S.J., Huang E.Y., Cronk D., Bagust J., Sharma R., Walker R.J., Wilson S., Burke J.F. A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett. 409:1997;426-430
37. Quelven I., Roussin A., Burlet-Schiltz O., Gouarderes C., Tafani J.A., Mazarguil H., Zajac J.M. Dissociation of pharmacological pro- and anti-opioid effects by neuropeptide FF analogs. Eur. J. Pharmacol. 449:2002;91-98
38. Rady J.J., Roerig S.C., Fujimoto J.M. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception. J. Pharmacol. Exp. Ther. 256:1991;448-457
39. Rothman R.B. A review of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse. 12:1992;129-138
40. Roumy M., Zajac J.M. Neuropeptide FF, pain and analgesia. Eur. J. Pharmacol. 345:1998;1-11
41. Roumy M., Zajac J.M. Neuropeptide FF receptors couple to a cholera toxin-sensitive G-protein in rat dorsal raphe neurones. Eur. J. Pharmacol. 417:2001;45-49
42. Roumy M., Garnier M., Zajac J.M. Neuropeptide FF receptors 1 and 2 exert an anti-opioid activity in acutely dissociated rat dorsal raphe and periventricular hypothalamic neurones. Neurosci. Lett. 348:2003;159-162
43. Vilim F.S., Ziff E. Cloning of the neuropeptide NPFF and NPAF precursor from bovine, rat, mouse and human. Abstract for the Society of Neuroscience USA, Congress San Diego, November:1995
44. West W.L., Yeomans D.C., Proudfit H.K. The function of noradrenergic neurons in mediating antinociception induced by electrical stimulation of the locus coeruleus in two different sources of Sprague-Dawley rats. Brain Res. 626:1993;127-135
45. Yang H.Y., Fratta W., Majane E.A., Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. U. S. A. 82:1985;7757-7761
46. Yano T., Iijima N., Kakihara K., Hinuma S., Tanaka M., Ibata Y. Localization and neuronal response of RFamide related peptides in the rat central nervous system. Brain Res. 982:2003;156-167
47. Zajac J.M. Neuropeptide FF: new molecular insights. Trends Pharmacol. Sci. 22:2001;63